Published in J Invest Dermatol on September 01, 1991
Comparison of real-time PCR signal-amplified in situ hybridization and conventional PCR for detection and quantification of human papillomavirus in archival cervical cancer tissue. J Clin Microbiol (2004) 1.03
Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch Dermatol Res (1994) 1.02
Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology (1998) 0.83
Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter. Br J Cancer (1995) 0.80
Nerve growth factor-beta induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology (2000) 0.80
Phenotypic characterization of skin lesions in urticaria pigmentosa and mastocytomas. Arch Dermatol Res (1995) 0.75
Comparative immunoreactivity of the eosinophil constituents MBP and ECP in different types of urticaria. Arch Dermatol Res (1995) 0.75
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res (1996) 2.86
IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol (1993) 2.44
Neonatal neutropenia in low birthweight premature infants. Am J Perinatol (1995) 1.74
Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol (1995) 1.54
Mast cells. Int J Dermatol (1995) 1.52
Fastest reduction of posttraumatic edema: continuous cryotherapy or intermittent impulse compression? Foot Ankle Int (1997) 1.52
Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol (1995) 1.50
Human mast cells produce IL-8. J Immunol (1993) 1.44
Is a single oral dose of ivermectin sufficient in crusted scabies? Int J Dermatol (2001) 1.44
Interferon treatment of patients with chronic urticaria and mastocytosis. J Am Acad Dermatol (1994) 1.39
[Recurrent nodular panniculitis in alpha 1-antitrypsin deficiency. Successful dapsone therapy]. Hautarzt (1993) 1.39
Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation. Cancer J Sci Am (2006) 1.38
Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol (1994) 1.34
The beta-tubulin gene family of Arabidopsis thaliana: preferential accumulation of the beta 1 transcript in roots. Gene (1988) 1.31
Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am J Pathol (1994) 1.30
Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187. J Immunol (1976) 1.27
Primary carcinoma of ectopic axillary breast tissue. J Eur Acad Dermatol Venereol (2006) 1.26
Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis. J Immunol (1976) 1.22
A murine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporin A. J Invest Dermatol (1994) 1.18
Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol (1994) 1.18
Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer. J Clin Oncol (1997) 1.16
Electron microscopical evidence for a direct contact between nerve fibres and mast cells. Acta Derm Venereol (1981) 1.15
Leukotriene B4 induces in vitro fibroblast chemotaxis. J Invest Dermatol (1984) 1.13
Stabilization of proximal tibial fractures with the LIS-System: early clinical experience in Berlin. Injury (2003) 1.10
Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol (1994) 1.08
Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours. J Pathol (1993) 1.08
Mast cell involvement in murine hair growth. Dev Biol (1994) 1.06
The beta-tubulin gene family in Zea mays: two differentially expressed beta-tubulin genes. Plant Mol Biol (1990) 1.04
Treatment of femoral shaft fractures in children by external fixation. Injury (1991) 1.02
Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch Dermatol Res (1994) 1.02
Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol (1999) 1.01
Psychiatric comorbidity: prevalence in methadone maintenance treatment. Am J Drug Alcohol Abuse (1996) 0.99
Magnetic resonance imaging in the diagnosis of acute injured distal tibiofibular syndesmosis. Invest Radiol (1997) 0.99
Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res (1994) 0.98
In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B4 and its w-oxidation products. Prostaglandins (1985) 0.98
Demonstration of the high-affinity IgE receptor on human Langerhans cells in normal and diseased skin. Br J Dermatol (1993) 0.97
Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med (1995) 0.97
Patterns of cell death: the significance of apoptosis for dermatology. Exp Dermatol (1993) 0.96
Hair growth induction by substance P. Lab Invest (1994) 0.96
Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin. J Invest Dermatol (1984) 0.95
Chemotaxis of human neutrophils and eosinophils towards leukotriene B4 and its 20-w-oxidation products in vitro. Prostaglandins (1986) 0.95
[Vertebroplasty and kyphoplasty in osteoporotic fractures of vertebral bodies -- a prospective 1-year follow-up analysis]. Rofo (2005) 0.95
Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1). J Invest Dermatol (1994) 0.94
Pinless external fixation. Indications and preliminary results in tibial shaft fractures. Clin Orthop Relat Res (1998) 0.94
Ultrastructural detection of Haemophilus ducreyi in biopsies of chancroid. Arch Dermatol Res (1978) 0.94
Biological and chemical characterization of eosinophil chemotactic factors from human leukocytes. Agents Actions Suppl (1983) 0.93
Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst (1995) 0.92
Chemotactic leukotrienes in psoriasis. Lancet (1982) 0.92
Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate. Br J Dermatol (1981) 0.91
Distribution and changing density of gamma-delta T cells in murine skin during the induced hair cycle. Br J Dermatol (1994) 0.91
P-glycoprotein expression in primary and metastatic malignant melanoma. Br J Dermatol (1995) 0.91
Ultrastructure of inclusions in peripheral blood mononuclear cells in sarcoidosis. Am J Pathol (1975) 0.91
Antitumour activity of paclitaxel and interferon-alpha in a case of metastatic eccrine porocarcinoma. J Eur Acad Dermatol Venereol (2004) 0.91
Substance P stimulates murine epidermal keratinocyte proliferation and dermal mast cell degranulation in situ. Arch Dermatol Res (1995) 0.91
Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities. Epilepsia (1994) 0.91
In vitro generation of mast cell-like cells from human peripheral mononuclear phagocytes. Int Arch Allergy Appl Immunol (1983) 0.90
Topical treatment of multiple actinic keratoses of the face with arotinoid methyl sulfone (Ro 14-9706) cream versus tretinoin cream: a double-blind, comparative study. J Am Acad Dermatol (1991) 0.90
Evidence that water acts as a carrier for an epidermal antigen in aquagenic urticaria. J Am Acad Dermatol (1986) 0.90
Identification of the bacteriophage T4 unf ( = alc) gene product, a protein involved in the shutoff of host transcription. Genetics (1984) 0.90
[Distal radius fracture. Fracture stabilization with biodegradable osteosynthesis pins (Biofix). Experimental studies and initial clinical experiences]. Unfallchirurg (1989) 0.90
Effect of 1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) on leukocytes I. Analysis of the in vitro migration of human neutrophils. Chem Phys Lipids (1981) 0.90
Erythema elevatum diutinum--evidence for disease-dependent leucocyte alterations and response to dapsone. Br J Dermatol (2000) 0.90
Glucocorticoid-induced modulation of cytokine secretion from normal and leukemic human myelomonocytic cells. Int Arch Allergy Immunol (1996) 0.90
Clinical experience with two types of pelvic C-clamps for unstable pelvic ring injuries. Injury (1996) 0.89
Morphology of the cellular infiltrate in delayed pressure urticaria. J Am Acad Dermatol (1985) 0.89
Allopurinol: a therapeutic alternative for disseminated cutaneous sarcoidosis. Br J Dermatol (1996) 0.89
Foreign-body granuloma and IgE-pseudolymphoma after multiple bee stings. Br J Dermatol (1994) 0.89
Mast cells as modulators of hair follicle cycling. Exp Dermatol (1995) 0.89
Development of human connective tissue mast cells from purified blood monocytes. Immunology (1984) 0.89
Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline. Acta Derm Venereol (1995) 0.89
Studies on the role of leukotrienes in murine allergic and irritant contact dermatitis. Br J Dermatol (1988) 0.88
Characterization of gene regulatory elements for selective gene expression in human melanoma cells. Biochem Biophys Res Commun (1995) 0.88
Monoclonal antibodies to leucosialin (CD43) induce homotypic aggregation of the human mast cell line HMC-1: characterization of leucosialin on HMC-1 cells. Immunology (1994) 0.87
[New perspectives in hair research: in search of the "biological clock" of the hair cycle]. Hautarzt (1992) 0.87
Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes. Arch Dermatol Res (1984) 0.87
In vitro differentiation of rat peritoneal macrophages into mast cells: an enzymecytochemical study. Blut (1982) 0.86
Primary leiomyosarcoma of the skin. A histological and immunohistochemical analysis. Acta Derm Venereol (1993) 0.86
Homologous growth hormone accelerates bone healing--a biomechanical and histological study. Bone (2003) 0.86
[Osteosynthesis of distal radius fractures with biodegradable fracture rods. Results of two years follow-up]. Unfallchirurg (1992) 0.86
Clinical, pharmacological and immunological aspects of delayed pressure urticaria. Br J Dermatol (1984) 0.86
Interleukin-6 expression in the skin of patients with lupus erythematosus. Exp Dermatol (1995) 0.86
[Percutaneous reduction and stabilization of a dislocated acetabular fracture. Case report]. Unfallchirurg (2006) 0.86
Expression of stem cell factor in cutaneous mastocytosis. Br J Dermatol (1995) 0.85
[Ipsilateral fractures of the proximal femur and the femoral shaft (author's transl)]. Unfallheilkunde (1980) 0.85
Nerve growth factor modulates keratinocyte proliferation in murine skin organ culture. Br J Dermatol (1994) 0.85
Correlation of proteolytic activities of organ cultured intact mouse skin with defined hair cycle stages. J Dermatol Sci (1994) 0.85
Production of LTB4-like chemotactic arachidonate metabolites from human keratinocytes. J Invest Dermatol (1985) 0.85
[Classification and management of complex pelvic trauma]. Unfallchirurg (1992) 0.85
Expression of classical and non-classical MHC class I antigens in murine hair follicles. Br J Dermatol (1994) 0.85
Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies. Dermatologica (1988) 0.85
[Periprosthetic infection]. Chirurg (2011) 0.85